CLINICAL_TRIALS
trial_result
· 2021-11-17
Clinical Trial Update: A Study to Compare Efficacy and Safety of CT-P17 With Humira in Patients With Active Rheumatoid Arthritis [Phase 3]
Summary
A Phase 3 study comparing CT-P17 to Humira in active rheumatoid arthritis has completed; results were posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Celltrion | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2021-11-17